93 related articles for article (PubMed ID: 28420927)
1. In silico analysis of fragile histidine triad involved in regression of carcinoma.
Rasheed MA; Tariq F; Afzal S; Mannanv S
J Pak Med Assoc; 2017 Apr; 67(4):616-621. PubMed ID: 28420927
[TBL] [Abstract][Full Text] [Related]
2. Loss of fragile histidine triad protein in human hepatocellular carcinoma.
Zhao P; Song X; Nin YY; Lu YL; Li XH
World J Gastroenterol; 2003 Jun; 9(6):1216-9. PubMed ID: 12800227
[TBL] [Abstract][Full Text] [Related]
3. Expression and Prognostic Role of FHIT, Fibronectin, and PTEN in Hepatocellular Carcinoma.
Zhang MJ; Yan Q; Zhang GL; Wie YH; Yuan WB; Xu W; Huang LF
Clin Lab; 2016 Jul; 62(7):1255-1264. PubMed ID: 28164627
[TBL] [Abstract][Full Text] [Related]
4. Reduced Fhit expression is associated with mismatch repair deficiency in human advanced colorectal carcinoma.
Andachi H; Yashima K; Koda M; Kawaguchi K; Kitamura A; Hosoda A; Kishimoto Y; Shiota G; Ito H; Makino M; Kaibara N; Kawasaki H; Murawaki Y
Br J Cancer; 2002 Aug; 87(4):441-5. PubMed ID: 12177781
[TBL] [Abstract][Full Text] [Related]
5. Expression of fragile histidine triad in primary hepatocellular carcinoma and its relation with cell proliferation and apoptosis.
Nan KJ; Ruan ZP; Jing Z; Qin HX; Wang HY; Guo H; Xu R
World J Gastroenterol; 2005 Jan; 11(2):228-31. PubMed ID: 15633221
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel proteins associated with hepatocellular carcinomas using protein microarrays.
Tannapfel A; Anhalt K; Häusermann P; Sommerer F; Benicke M; Uhlmann D; Witzigmann H; Hauss J; Wittekind C
J Pathol; 2003 Oct; 201(2):238-49. PubMed ID: 14517841
[TBL] [Abstract][Full Text] [Related]
7. Aberrant methylation of Fragile Histidine Triad gene is associated with poor prognosis in early stage esophageal squamous cell carcinoma.
Lee EJ; Lee BB; Kim JW; Shim YM; Hoseok I; Han J; Cho EY; Park J; Kim DH
Eur J Cancer; 2006 May; 42(7):972-80. PubMed ID: 16564166
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical evaluation of p53, FHIT, and IGF2 gene expression in esophageal cancer.
Chava S; Mohan V; Shetty PJ; Manolla ML; Vaidya S; Khan IA; Waseem GL; Boddala P; Ahuja YR; Hasan Q
Dis Esophagus; 2012 Jan; 25(1):81-7. PubMed ID: 21668571
[TBL] [Abstract][Full Text] [Related]
9. Low expression of FHIT and PTEN correlates with malignancy of gastric carcinomas: tissue-array findings.
Zheng H; Takahashi H; Murai Y; Cui Z; Nomoto K; Tsuneyama K; Takano Y
Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):432-40. PubMed ID: 18091387
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathological significance of aberrant methylation of the fragile histidine triad gene in patients with hepatocellular carcinoma].
Sun Y; Geng XP; Zhu LX; Xiong QR; Qian YB; Dong GY; Li XM
Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):609-12. PubMed ID: 16784654
[TBL] [Abstract][Full Text] [Related]
11. Influence of DNA methyltransferase 3b on FHIT expression and DNA methylation of the FHIT promoter region in hepatoma SMMC-7721 cells.
Wang JX; Zhang YG; Zhao LS
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):273-7. PubMed ID: 19502167
[TBL] [Abstract][Full Text] [Related]
12. Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis.
Gramantieri L; Chieco P; Di Tomaso M; Masi L; Piscaglia F; Brillanti S; Gaiani S; Valgimigli M; Mazziotti A; Bolondi L
Clin Cancer Res; 1999 Nov; 5(11):3468-75. PubMed ID: 10589760
[TBL] [Abstract][Full Text] [Related]
13. [Fragile histidine triad protein expression and correlation with apoptosis in rectal carcinoma].
Cao J; Xia J; Wang H; DU H; Li WL
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Mar; 10(2):177-81. PubMed ID: 17380463
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics analysis of metastasis-related proteins in hepatocellular carcinoma.
Song PM; Zhang Y; He YF; Bao HM; Luo JH; Liu YK; Yang PY; Chen X
World J Gastroenterol; 2008 Oct; 14(38):5816-22. PubMed ID: 18855979
[TBL] [Abstract][Full Text] [Related]
15. Alterations of the fragile histidine triad gene in hepatitis C virus-associated hepatocellular carcinoma.
Zekri AR; Bahnassy AA; Hafez M; El-Shehaby AM; Sherif GM; Khaled HM; Zakhary N
J Gastroenterol Hepatol; 2005 Jan; 20(1):87-94. PubMed ID: 15610452
[TBL] [Abstract][Full Text] [Related]
16. Implication of mitochondrial involvement in apoptotic activity of fragile histidine triad gene: application of synchronous luminescence spectroscopy.
Askari MD; Vo-Dinh T
Biopolymers; 2004 Mar; 73(4):510-23. PubMed ID: 14991669
[TBL] [Abstract][Full Text] [Related]
17. Nicotine induces the fragile histidine triad methylation in human esophageal squamous epithelial cells.
Soma T; Kaganoi J; Kawabe A; Kondo K; Imamura M; Shimada Y
Int J Cancer; 2006 Sep; 119(5):1023-7. PubMed ID: 16570269
[TBL] [Abstract][Full Text] [Related]
18. Loss of fragile histidine triad (FHIT) expression and microsatellite instability in periocular sebaceous gland carcinoma in patients with Muir-Torre syndrome.
Holbach LM; von Moller A; Decker C; Jünemann AG; Rummelt-Hofmann C; Ballhausen WG
Am J Ophthalmol; 2002 Jul; 134(1):147-8. PubMed ID: 12095833
[TBL] [Abstract][Full Text] [Related]
19. The Fragile Histidine Triad gene and breast cancer.
Yang Q; Yoshimura G; Sakurai T; Kakudo K
Med Sci Monit; 2002 Jul; 8(7):RA140-4. PubMed ID: 12118213
[TBL] [Abstract][Full Text] [Related]
20. Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions.
Hao XP; Willis JE; Pretlow TG; Rao JS; MacLennan GT; Talbot IC; Pretlow TP
Cancer Res; 2000 Jan; 60(1):18-21. PubMed ID: 10646844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]